From stigmatisation to innovation, India’s path towards responsible harnessing of its ancient botanical treasure for bioeconomy and medicine
It is an enduring principle in nature that redundancy is rare. Wild flora, especially those with ancient evolutionary trajectories, often possess intrinsic ecological, nutritional, or therapeutic significance. One such plant is Cannabis Sativa, having a wild origin and a deep cultural ancestry.
Historically, this plant has been celebrated across civilisations, remarkably as a resilient species having served as a botanical cornerstone in Ayurvedic, Chinese, Egyptian, and Middle Eastern medicinal systems. Cannabis sativa, valued for its analgesic, anxiolytic, anti-inflammatory, and neuroprotective properties, was once an integral part of healing traditions, spiritual practices, and agrarian economies. However, modern narratives have narrowly defined the plant through the prism of its psychoactive components, dronabinol and its stereoisomers (delta-9-tetrahydrocannabinol), and tetrahydrocannabinol, thereby contributing to its widespread criminalisation and stigmatisation.
This myopic focus on substance abuse potential has resulted in reactive policies, such as routine destruction of naturally occurring cannabis in regions like Jammu & Kashmir, without evaluating its broader ecological, therapeutic, and industrial relevance. Law enforcement interventions, though often justified under public health and narcotic control mandates, ironically undermine emerging evidence that the plant harbours substantial untapped value in areas far beyond recreational misuse. As such, a transformative shift is not only desirable but urgent in contemporary times.
Countries such as New Zealand, Canada, Germany, Israel, Thailand, and others have begun re-regulating cannabis research and commercial use to leverage its medicinal and bio-industrial capacities. In a decisive step, the Government of Himachal Pradesh has launched pilot studies aimed at regulated cultivation for pharmaceutical and industrial purposes. These initiatives reflect a growing global consensus that Cannabis sativa is not merely a plant to be eradicated but a bio-resource to be responsibly harnessed.
In the context of Jammu & Kashmir, where the plant grows abundantly in the wild, its potential assumes added significance. Here, cannabis could anchor a new wave of local biotechnological innovation, offering sustainable livelihoods, agricultural diversification, and ecologically sound practices. Most critically, the microbiome of Cannabis sativa—comprising a complex and largely unexplored consortium of bacteria, fungi, and endophytes—could redefine our understanding of plant resilience, metabolite biosynthesis, and soil symbiosis. Cutting-edge fields like metagenomics, synthetic biology, and precision fermentation can help unravel how microbial interactions modulate cannabinoid expression, pathogen resistance, and environmental adaptability.
Harnessing the microbial potential associated with Cannabis sativa opens transformative avenues across sectors, enabling a paradigm shift from prohibitionist narratives to bioeconomic innovations. The strategic integration of cannabis and its microbiome presents unprecedented opportunities for cross-disciplinary breakthroughs, including:
1. Sustainable agriculture—through the development of cannabis-specific biofertilizers and biostimulants that can significantly reduce chemical input reliance. Leveraging endophytic and rhizospheric microbial symbioses enhances nutrient assimilation, soil vitality, and crop resilience.
2. Agroecological resilience—through its nitrogen-fixation facilitation via associative microbial consortia, while its inherent pest resistance minimises agrochemical dependency, supporting integrated pest management (IPM).
3. Pharmaceutical frontiers—through advancements in metagenomics and precision fermentation that can amplify rare cannabinoid biosynthesis (e.g., cannabigerol, tetrahydrocannabivarin), enabling therapeutic applications in oncology, neurology, and immunology. Cannabis-microbe co-evolution may further unlock novel bioactive flavonoids.
4. Synthetic biology and metabolic engineering—through CRISPR-based genomic editing and microbial chassis development, synthetic pathways can be optimised to produce bespoke cannabinoid profiles, catalysing a new era in personalised medicine.
5. Green biotechnology and biorefining—using hemp biomass to offer low-carbon alternatives such as hempcrete, bioplastics, and protein-rich animal feed. Microbial processing enhances material properties and yields, promoting circular economy models.
6. Textile and materials science—through hemp fibres, which, when processed via enzyme-assisted bio-degumming, yield high-tensile, biodegradable materials suitable for packaging, construction, and composite fabrication, outperforming conventional synthetics in sustainability indices.
7. Soil and ecosystem restoration—via phytoremediation potential that is amplified when cannabis is coupled with pollutant-degrading microbial consortia. This approach is especially relevant for detoxifying heavy metals and organic pollutants in post-industrial, post-conflict, or mining-degraded landscapes.
Realising this multifaceted potential requires a transdisciplinary research ecosystem, uniting plant geneticists, soil microbiologists, systems biotechnologists, economists, policy scholars, and indigenous knowledge holders. Localised pilot projects should be appreciated and aligned with global partnerships, with strict adherence to bioethical standards, biodiversity preservation, and equitable benefit-sharing protocols.
This reframing of Cannabis sativa—from a stigmatised plant to a cornerstone of regenerative innovation—is not merely academic but an ecological and socio-economic imperative. It calls for deliberate dismantling of outdated legal regimes and the adoption of evidence-based, ethics-driven policy reform that supports community-centric innovation, especially among tribal and rural populations. These communities, when empowered through ethical cultivation frameworks and integration of traditional ecological knowledge, can serve as custodians of biodiversity and drivers of local value chains.
Such a vision aligns powerfully with the UN Sustainable Development Goals (SDGs) that aim to (a) advance health and well-being, (b) promote responsible consumption, (c) address climate change, and (d) foster inclusive economic growth. Going forward, decriminalisation must be accompanied by strategic regulatory infrastructure, investment in biobanks, regional cannabinoid libraries, and quality-controlled cultivation protocols. Cannabis, in this context, emerges not as a symbol of counterculture but as a biological keystone in crafting a more sustainable, equitable, and resilient future.
The historical disjuncture of Cannabis sativa from medicinal heritage to criminalised misuse
The historical trajectory of Cannabis sativa in India exemplifies a profound epistemic and regulatory disjuncture. Essentially, it reveals an artificial rupture that has decoupled millennia of cultural reverence and medicinal integration from contemporary frameworks of prohibition, stigma, and systemic neglect.
Ancient Indian medical texts, including the Sushruta Samhita, Charaka Samhita, and Atharva Veda, provide extensive references to cannabis, affirming its use in managing a spectrum of physiological and psychological conditions such as pain, digestive disorders, fever, anxiety, and spiritual malaise. The Unani and Siddha systems of medicine similarly recognised the plant’s anxiolytic, anti-inflammatory, and tonic properties, often incorporating cannabis into compound therapeutics aligned with a holistic understanding of health and well-being.
However, the onset of colonial jurisprudence and its codification of drug control laws—especially under the influence of imperial anxieties around ‘native intoxicants’—catalysed a paradigmatic shift. These laws systematically eroded indigenous epistemologies while re-inscribing Cannabis sativa as a vector of criminality rather than a cure. This disruption was institutionalised with the enactment of the Narcotic Drugs and Psychotropic Substances (NDPS) Act in 1985, which imposed a blanket criminalisation on cannabis irrespective of chemotype, potency, or intended use—be it industrial hemp, therapeutic resin, or wild botanicals.
This undifferentiated approach not only delegitimised centuries of traditional knowledge systems but also foreclosed opportunities for scientific investigation, pharmacological exploration, and sustainable economic development.
In ecological contexts such as Jammu & Kashmir, where Cannabis sativa proliferates naturally across diverse agro-climatic zones, this prohibitionist stance manifests in indiscriminate eradication drives. These operations, often justified as law enforcement measures, overlook the plant’s immense pharmaceutical, industrial, and environmental potential. Consequently, communities are deprived of livelihood options, research remains stifled, and a bioresource of global significance is continually wasted.
In stark contrast, international regulatory landscapes are undergoing a transformative renaissance. Over fifty countries have enacted medical cannabis reforms, investing in cannabinoid science, agri-biotechnology, and green industrial applications. The 2020 resolution by the United Nations Commission on Narcotic Drugs (CND) to remove cannabis from Schedule IV of the 1961 Single Convention on Narcotic Drugs marks a significant shift in global drug policy, recognising its therapeutic potential based on WHO recommendations.
Countries such as Israel, Canada, Germany, and Colombia are at the forefront of this movement, leveraging advanced R&D ecosystems to pioneer breakthroughs in endocannabinoid pharmacology, microbial genomics, precision breeding, and sustainable material engineering. India’s continued abstention from this global recalibration—despite possessing vast endemic cannabis biodiversity, a deep pharmaco-botanical heritage, and world-class talent—represents not only a policy void but a strategic economic and scientific omission.
Reintegrating Cannabis sativa into legitimate research, healthcare, and green enterprise frameworks is not merely an act of restitution but an essential step in aligning national priorities with emerging global bioeconomic paradigms.
A tale of destruction over development
Despite its unparalleled agro-climatic diversity and deep-rooted ethnobotanical legacy, India remains conspicuously absent from the evolving global cannabis narrative. This paradox is particularly evident in Jammu & Kashmir, where Cannabis sativa flourishes as a naturally occurring species—genetically diverse, ecologically resilient, and biochemically endowed with a range of high-value cannabinoids and terpenoids.
Rather than capitalising on this unique phytogenetic resource for therapeutic innovation, industrial bioproducts, or genomic research, the current state response remains one of criminalisation and eradication. Genetically rich wild strains are potential goldmines for pharmaceutical, agronomic, and material sciences, yet they are routinely destroyed under prohibitionist mandates—representing an incalculable loss to biodiversity and the bioeconomy.
Nonetheless, signs of policy recalibration are emerging. Progressive licensing frameworks for industrial hemp cultivation have been initiated in Himachal Pradesh, Uttarakhand, and Madhya Pradesh—early indicators of a shifting regulatory tide. Parallel to this, premier scientific institutions under ICAR and CSIR have launched foundational studies into cannabis chemotyping, value-added processing technologies, and agro-industrial integration.
However, in the absence of a coherent national roadmap—including legislative reform, mission-mode R&D funding, robust quality standards, and structured public awareness campaigns—these fragmented efforts risk stagnation. Harnessing cannabis as a strategic bio-resource requires moving beyond punitive legacies to a science-driven, ethically governed, and innovation-centric framework.
A coordinated approach that integrates state-led research, tribal knowledge systems, sustainable cultivation models, and international best practices is not only timely but essential for India’s inclusive green transition and participation in the expanding global cannabinoid economy.
Cross-sectoral applications of Cannabis sativa
Contemporary scientific consensus now recognises Cannabis sativa not as a controversial anomaly, but as a polyfunctional botanical platform of exceptional biomedical, agronomic, and industrial relevance. Far from the reductive dichotomy of “drug” versus “medicine,” this species embodies a convergence of disciplines—from molecular pharmacology and plant genetics to environmental sustainability and rural innovation.
Phytochemically, Cannabis sativa produces over 140 characterised cannabinoids—including Δ9-THC, CBD, CBG, and CBC—alongside a complex matrix of terpenoids and flavonoids. These bioactive compounds influence the human endocannabinoid system, modulating neuroimmune homeostasis, neuroprotection, synaptic plasticity, and inflammatory cascades. Consequently, cannabis-based therapies hold promise for treating chronic and treatment-resistant conditions such as epilepsy, multiple sclerosis, Parkinson’s disease, chronic pain syndromes, autoimmune disorders, and certain cancers.
Beyond therapeutics, hemp cultivars showcase profound agronomic and environmental potential. As a climate-resilient, low-input crop, hemp is suitable for marginal soils and arid conditions, making it an ideal candidate for ecological restoration and livelihood diversification in resource-constrained regions. Its rapid biomass accumulation and deep root systems contribute to carbon sequestration, phytoremediation, and regenerative agriculture frameworks.
Industrially, hemp’s fibres exhibit tensile strengths and biodegradability that surpass many synthetics, opening scalable avenues in textiles, construction (hempcrete), biocomposites, and automotive components. Nutritionally, hemp seeds provide a complete amino acid profile and an optimal balance of omega-3 to omega-6 fatty acids, positioning them as next-generation superfoods for both human and animal nutrition. Simultaneously, emerging applications in cannabis-based biofuels, bioplastics, and cosmetics are anchoring the plant within global value chains driven by sustainability and circular economy principles.
In essence, Cannabis sativa is not merely a plant, but a bioeconomic vector capable of driving interdisciplinary innovation across health, agriculture, climate, and development sectors. Achieving its full potential necessitates strategic investments, regulatory foresight, and alignment between science, policy, and industry.
Cannabis microbiome as a hidden engine of biochemical potential
An emerging frontier in Cannabis sativa research concerns its rhizospheric and endophytic microbiome—a dynamic and largely unexplored ecological interface that plays a pivotal role in plant health, secondary metabolite biosynthesis, and environmental adaptability. These microbial consortia, residing both in the root zone and within plant tissues, influence nutrient cycling, stress tolerance, and the biosynthesis pathways responsible for key phytochemicals such as cannabinoids, terpenes, and flavonoids.
Advanced multi-omics platforms—including metagenomics, transcriptomics, metabolomics, and proteomics—coupled with artificial intelligence and machine learning, now enable high-resolution mapping of microbiome-host interactions. Such integrative approaches can facilitate strain-specific microbiome engineering, leading to enhanced phytochemical consistency, pest and disease resistance, and yield optimisation.
This paradigm of “precision phytopharming” harnesses microbial signatures to standardise and tailor cannabis outputs for pharmaceutical, nutraceutical, and industrial applications. India, with its robust infrastructure in microbial genomics and computational biology—exemplified by institutions such as the National Institute of Biomedical Genomics (NIBMG) and the Institute of Genomics and Integrative Biology (IGIB)—is uniquely positioned to become a global leader in cannabis microbiome research.
Aligning this research within national strategies like the National Biotechnology Development Strategy (NBDS), Digital India, and the National Mission on Sustainable Agriculture (NMSA) can catalyse high-value intellectual property, rural biotech entrepreneurship, and strengthen India’s standing in the emerging global cannabis economy. Critical to this endeavour are enabling regulatory frameworks, interdisciplinary collaborations, and international partnerships—particularly in bioinformatics, metabolite pathway engineering, and microbiome-based product development.
A comprehensive platform integrating cannabis microbiome research with ethical bioprospecting, indigenous knowledge, and GMP standards could serve as a cornerstone for the nation’s future-ready bioeconomy.
Policy, ethics, and governance with respect to Cannabis research for scientific recalibration
The path forward demands a scientifically grounded, ethically conscious, and context-sensitive governance architecture—one that moves beyond the punitive legacies of colonial-era narcotics laws and adopts an evidence-based, nuanced approach to the various forms and uses of Cannabis sativa. This shift must recognise cannabis not as a monolithic “drug,” but as a polyvalent botanical asset with industrial, medicinal, nutritional, and cultural dimensions.
Key policy imperatives include:
– Clear regulatory thresholds for phytochemicals, particularly THC and CBD, aligned with global pharmacovigilance standards.
– Differentiated licensing regimes for low-THC industrial hemp and high-value medical cannabis, enabling cultivation, processing, research, and export within transparent and accountable frameworks.
– GMP-compliant clinical research pathways, integrated with AYUSH, ICMR, and other national protocols, to generate evidence and validate products across therapeutic areas.
– Mainstreaming cannabis into India’s innovation and startup ecosystems, including support under the National Biopharma Mission, Startup India, and Atal Innovation Mission.
– Inclusion of indigenous knowledge-holders, tribal communities, and rural cultivators through equitable IPR models and benefit-sharing mechanisms under India’s Biodiversity Act and Nagoya Protocol obligations.
– Promoting sustainable cultivation practices, incentivised through carbon credits, agroecological standards, and circular bioeconomy models.
This recalibration must prioritise bioethics, environmental sustainability, and restorative justice—particularly in marginalised regions such as Jammu & Kashmir. Here, a well-regulated cannabis economy, rooted in local participation, ecological resilience, and scientific rigour, could serve as a catalyst for peacebuilding, employment, and place-based innovation.
In conclusion, Cannabis sativa—especially in its wild and uncultivated ecotypes—stands as a living testament to India’s biocultural resilience and ecological ingenuity. To reduce it to a criminal artefact is a grave scientific and ethical error. Its prohibition has silenced centuries of indigenous knowledge, hindered therapeutic potentials, and marginalised communities coexisting with this plant.
In Jammu & Kashmir, a region rich in ethnobotanical traditions and facing post-conflict and developmental challenges, strategic decriminalisation and reintegration of cannabis into scientific, healthcare, and socio-economic frameworks is no longer optional but an urgent necessity. The moment calls for deliberate action—anchored in progressive policy, cutting-edge science, and inclusive ethics—to revive India’s ancient legacy and position itself as a global leader in sustainable phytopharmaceutical innovation, green economies, and soft power diplomacy for the 21st century.
About the writer
Dr Sami Ullah is a forensic practitioner, anthropologist, and social worker with MSc, PhD in Forensic Science and an MA in Anthropology. As Co-Founder and Chairman of the RADISAT Foundation, he works at the intersection of science, policy, and indigenous knowledge. His research explores the socio-legal and biocultural dimensions of cannabis in India, focusing on sustainable innovation and evidence-based reform in regions like Jammu & Kashmir.
Dr Sami Ullah
sa********@***il.com